ICGN - Icagen, Inc.

[welcommen]

ICGN set to skyrocket at the beginning of next week!

Let’s go direct to the points, no bullshit.

1, ICGN is going to report Q2 earning on 8/04/2009, couple II stage
clinical trials are due to release. Please check FDA calendar, as I
see from it, Senicapoc will finish II stage clinical trial in August.
The status ICA-105665 for neuropathic pain will be updated too. Once
we got the positive data, there will be an at least 50% jump!

2, ICGN has tons of cash in hand, see the balance below (from 10Q):

cagen, Inc.
Condensed Balance Sheets
(in thousands, except share and per share data)

March 31, 2009 December 31, 2008
(unaudited)
Assets
Current assets:
Cash and cash equivalents $ 29,294 $ 34,215
Accounts receivable 12 14
Prepaid expenses and other 1,682 568

Total current assets 30,988 34,797
Non-current assets:
Property and equipment, net 2,425 2,586
Technology licenses and related costs, net of accumulated amortization
of $388 and $383 as of March 31, 2009 and December 31, 2008,
respectively 373 392
Deposits and other 144 105

Total assets $ 33,930 $ 37,880

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable $ 2,638 $ 1,436
Accrued expenses 714 892
Current portion of deferred revenue 3,878 5,378
Current portion of equipment debt financing 562 662

Total current liabilities 7,792 8,368
Total liabilities and stockholders’ equity $ 33,930 $
37,880

I think most of the small cap. companies will envy for such kind of
cash reserve. That is why ICGN could speak confidently so loud: “The
Company believes its existing cash and cash equivalents will be
sufficient to enable it to fund its operating expenses, obligations
under its equipment debt financing and capital expenditure
requirements through the second quarter of 2010.” Furthermore, ICGN
keeps getting milestone payments from her sugar daddy Pfizer, and
Pfizer had promised 359 million dollars for the trials!!! ICGN had
burned 130 million only since this company was founded!!!!(from 10Q)

Why the stock price of ICGN is so low?

God **** the financial crisis! And ICA-105665 for epilepsy was
suspended by FDA, because FDA found that high dose ICA-105665 might
cause some abnormal behavior in animal trial. FDA requested that ICGN
should do extra animal trail before continue II stage clinical trial,
but it wont affect the trial of neuropathic pain.

I am now expecting the statistics of the animal trial, it is ongoing
for 3 months already and it is time to release the news. Once restrict
was released by FDA, please refer to NLTX. NLTX climbed rapidly from
$0.25 to $2 when its drug suspension was released by FDA. How similar
the situation is!!!

I predict ICGN will at least pass $1 early next month. Lets wait and
see!

[marketwatch]

Wish I had stayed on board for the 124% day a few weeks back but had sold out long before that and got back on board during the run up. It and had another nice run today of 30%. The reason for all the excitement lately is because Phizer (PFE) filed a few weeks ago that they are looking into a strategic transaction between the 2 companies. ICGN current Market Cap is 58.87M.

[Lucifer]

Wish I had stayed on board for the 124% day a few weeks back but had sold out long before that and got back on board during the run up. It and had another nice run today of 30%. The reason for all the excitement lately is because Phizer (PFE) filed a few weeks ago that they are looking into a strategic transaction between the 2 companies. ICGN current Market Cap is 58.87M.

U Da Man marketwatch!!
Are you staying long or are you rotating off to another sleeper?
Thanks, Luc.